The role of Keratosept® drops in perioperative prophylaxis in patients undergoing intravitreal injections
OphthaTherapy. Therapies in Ophthalmology · 31.12.2025 · 12 (4) · 385-388
DOI: 10.24292/01.ot.010126 ↗Kurz gefasst
Fachartikel in der Zeitschrift OphthaTherapy. Therapies in Ophthalmology, online erschienen am 31.12.2025. Verfasst von Marek Prost.
Abstract (Originalsprache)
In ophthalmology intravitreal injections are one of the most commonly performed procedures. The most dangerous complication after the procedure is endophthalmitis. The most commonly used preventive measure is the application of povidone-iodine solution before and after the procedure. However, povidone has a cytotoxic effect on the epithelium of the eye surface. Therefore, it is advisable to in still Keratosept eye drops (containing 3 antiseptics, dexpanthenol, and polyvinyl alcohol) 2 days before the procedure and 3 days after to sterilize the surface of the eye before and after the injection and to facilitate the healing of changes in the conjunctival and corneal epithelium after the procedure.
Zitieren
APA
Prost, M. (2025). The role of Keratosept® drops in perioperative prophylaxis in patients undergoing intravitreal injections. OphthaTherapy. Therapies in Ophthalmology, 12(4), 385-388. https://doi.org/10.24292/01.ot.010126
Vancouver
Prost M. The role of Keratosept® drops in perioperative prophylaxis in patients undergoing intravitreal injections. OphthaTherapy. Therapies in Ophthalmology. 2025;12(4):385-388. doi:10.24292/01.ot.010126
BibTeX
@article{Prost2025,
author = {Prost, Marek},
title = {The role of Keratosept® drops in perioperative prophylaxis in patients undergoing intravitreal injections},
journal = {OphthaTherapy. Therapies in Ophthalmology},
year = {2025},
volume = {12},
number = {4},
pages = {385--388},
doi = {10.24292/01.ot.010126}
}
EUVIMED